Home
ChemCon GmbH logo
ChemCon GmbH

ChemCon GmbH

1.0K
74
13
4.0(8)

About Company

  • Legal Name: ChemCon GmbH
  • Registered country: Germany
  • Address: Engesserstr. 4b D-79108 Freiburg i. Br.
  • Number of employees: 100 - 249
Description:

ChemCon GmbH, located in Freiburg, Germany, is your contract development and manufacturing partner for APIs and fine chemicals specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes. Our inspected facilities (inspected by FDA and German authorities, 16-times) are optimized for the production of small to medium quantities. With multidisciplinary expertise, we can meet your individual demands for small-molecule organic APIs, inorganic compounds and polymers. Comprehensive in-house analytics, stability studies (ICH-compliant), documentation, and regulatory support complete our services.

Business Activities

Pharma Chemicals

ManufacturerContract ManufacturerAPI ManufacturerExcipient SupplierTesting LaboratoryRaw Material Supplier

Laboratory & Analytical Services

ManufacturerService ProviderContract ManufacturerAPI ManufacturerExcipient SupplierTesting LaboratoryRaw Material Supplier

Contract & Outsourcing Services

Service Provider

Regulatory & Market Intelligence Services

Service Provider

Our Products & Services

Sell · Active Pharmaceutical Ingredients (APIs)
Arsenic Trioxide - ChemCon GmbH
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Methylene Blue - ChemCon GmbH
Sell · Active Pharmaceutical Ingredients (APIs)
Selenious Acid - ChemCon GmbH
Sell · Active Pharmaceutical Ingredients (APIs)
Sodium Selenite
Sell · Active Pharmaceutical Ingredients (APIs)
Manganese Chloride
Sell · Active Pharmaceutical Ingredients (APIs)
Copper Chloride
Sell · Active Pharmaceutical Ingredients (APIs)
Zinc Dichloride

Certifications

DMF

FDA

GMP

Proofs

CPHI Americas 2026
CPHI Americas 2026
06/2026 – 06/2026

CPHI Americas 2026

Location
Pennsylvania Convention Center, Philadelphia
Filters:
Sort by:

    No comments available.